Kevin Heyeck

Chief Executive Officer at Chimeron Bio.

Raised on Chimeron Bio filings

$12.8M

across 1 Form D filing

Company

Biotech · Philadelphia, PA

Self-amplifying RNA medicines and vaccines

Self-amplifying RNA medicines and vaccines

Chimeron Bio Form D filings
Filed	Security	Sold of offered	Filing
Mar 14, 2025	Equity	$12.8M/ no target	Form D/A

Also named on Chimeron Bio filings